Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts
2017 · Journal of Translational Medicine · 43 citations
https://doi.org/10.1186/s12967-016-1095-2
D
Davide Soldato
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
74
Papers
901
Citations
17
h-index
22
i10-index
Davide Soldato is an academic researcher from Azienda Ospedaliera S.Maria. The author has contributed to research in topics: Cancer survivorship and care & Cancer Risks and Factors & Cancer Immunotherapy and Biomarkers. The author has an h-index of 17, co-authored 63 publications.
ORCID: 0000-0002-2090-3245Papers by this author
worksThe Future of Breast Cancer Research in the Survivorship Field
2023 · Oncology and Therapy · 34 citations
https://doi.org/10.1007/s40487-023-00225-8
Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients
2021 · npj Precision Oncology · 19 citations
https://doi.org/10.1038/s41698-021-00230-y
A bio-behavioral model of systemic inflammation at breast cancer diagnosis and fatigue of clinical importance 2 years later
2024 · Annals of Oncology · 16 citations
https://doi.org/10.1016/j.annonc.2024.07.728
Factors associated with enrolment in clinical trials among women with early-stage breast cancer
2022 · ESMO Open · 8 citations
https://doi.org/10.1016/j.esmoop.2022.100513
Immunotherapy beyond progression combined with platinum-based chemotherapy after primary resistance to first-line immunotherapy in patients with advanced NSCLC and PD-L1 ≥50%
2025 · ESMO Open · 0 citations
https://doi.org/10.1016/j.esmoop.2025.105897
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat